Starting with a limited set of samples and metadata for training (diseased versus control animals), a phenotype of type II diabetes was defined and led to the discovery of potential new biomarkers and therapeutic targets for the disease.
- Whole blood from C57BL/6 mice – 2uL volume
- 100% specificity and 100% sensitivity on sample classification using Probius signature and biomarker network
- A posteriori analysis of disease pathways involving immune response and glucose and fatty acid metabolism
To request the full case study please use our contact form.